Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials

Arch Pharm Res. 2021 Apr;44(4):354-377. doi: 10.1007/s12272-021-01319-5. Epub 2021 Mar 24.

Abstract

Canonical transient receptor potential channels (TRPCs) are nonselective, high calcium permeability cationic channels. The TRPCs family includes TRPC1, TRPC2, TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7. These channels are widely expressed in the cardiovascular and nervous systems and exist in many other human tissues and cell types, playing several crucial roles in the human physiological and pathological processes. Hence, the emergence of TRPCs modulators can help investigate these channels' applications in health and disease. It is worth noting that the TRPCs subfamilies have structural and functional similarities, which presents a significant difficulty in screening and discovering of TRPCs modulators. In the past few years, only a limited number of selective modulators of TRPCs were detected; thus, additional research on more potent and more selective TRPCs modulators is needed. The present review focuses on the striking desired therapeutic effects of TRPCs modulators, which provides intel on the structural modification of TRPCs modulators and further pharmacological research. Importantly, TRPCs modulators can significantly facilitate future studies of TRPCs and TRPCs related diseases.

Keywords: Calcium ion; Canonical transient receptor potential channels modulators; Drug discovery; High-resolution structures; Therapeutic potentials.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology*
  • Disease
  • Humans
  • TRPC Cation Channels / metabolism*

Substances

  • Anti-Inflammatory Agents
  • TRPC Cation Channels